TARO-LISDEXAMFETAMINE CHEWABLE TABLETS

Identification of Taro-Lisdexamfetamine Chewable Tablets

No description

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 30 MG

DIN: 02533367

Dosage form(s): TABLET (CHEWABLE)

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: TARO PHARMACEUTICALS INC

Date: 04-JUN-2024

ATC:

Reference brand drug: Vyvanse

Search on Google

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-lisdexamfetamine chewable tablets photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.